-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
-
Summary
-
G1 Therapeutics, Inc. annual Current Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
- G1 Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2023 was $3.12M, a 83.2% increase from 2022.
- G1 Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2022 was $1.7M, a 83.8% increase from 2021.
- G1 Therapeutics, Inc. annual Current Income Tax Expense (Benefit) for 2021 was $925K, a 34.4% decline from 2020.
Current Income Tax Expense (Benefit), Annual (USD)
Current Income Tax Expense (Benefit), YoY Annual Growth (%)